Twenty years of lesson learning: how does theRETgenetic screening test impact the clinical management of medullary thyroid cancer?

Multiple Endocrine Neoplasia Type 2 and Familial Medullary Thyroid Carcinoma: An Update

(2013) Samuel A. Wells et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

High prevalence of exon 8 G533C mutation in apparently sporadic medullary thyroid carcinoma in Greece

(2012) H. L. Sarika et al.   CLINICAL ENDOCRINOLOGY

The Hirschsprung's–multiple endocrine neoplasia connection

(2012) SW Moore et al.   Clinics

Low Prevalence of the Somatic M918T RET Mutation in Micro-Medullary Thyroid Cancer

(2012) Cristina Romei et al.   THYROID

In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer

(2011) B Cosci et al.   ENDOCRINE-RELATED CANCER

The Timing of Total Thyroidectomy inRETGene Mutation Carriers Could Be Personalized and Safely Planned on the Basis of Serum Calcitonin: 18 Years Experience at One Single Center

(2011) Rossella Elisei et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)

(2010) C. Romei et al.   CLINICAL ENDOCRINOLOGY

Familial associations in medullary thyroid carcinoma with Hirschsprung disease: the role of the RET-C620 “Janus” genetic variation

(2010) Sam W. Moore et al.   JOURNAL OF PEDIATRIC SURGERY

Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association

(2009) Richard T. Kloos (Chair) et al.   THYROID

Routine serum calcitonin measurement in the evaluation of thyroid nodules

(2008) Rossella Elisei   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Familial prevalence and age of RET germline mutations: implications for screening

(2008) Andreas Machens et al.   CLINICAL ENDOCRINOLOGY

Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene

(2008) Melpomeni Peppa et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Prognostic Significance of SomaticRETOncogene Mutations in Sporadic Medullary Thyroid Cancer: A 10-Year Follow-Up Study

(2007) Rossella Elisei et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM